Taiwan’s president receives domestically produced COVID-19 vaccine

Taiwanese President Tsai Ing-wen receives her first dose of the two-dose Medigen Vaccine Biologics Corp. vaccine on Monday at Taipei's Taiwan University Hospital. Photo courtesy of Taiwan President Tsai Ing-wen/Facebook

Aug. 23 (UPI) — Taiwanese President Tsai Ing-wen received her first dose of a domestically produced COVID-19 vaccine on Monday as it began its rollout of the two-shot regimen.

Tsai, at a gymnasium in Taipei’s Taiwan University Hospital, received her shot of the vaccine by Medigen Vaccine Biologics Corp., which was approved for use last month, her office said in a statement.

As of Friday, nearly 39% of Taiwan has received at least one shot with only 3.24% being fully vaccinated, according to Oxford University’s Our World In Data project.

Health officials in Taipei had previously authorized the administration of vaccines by AstraZeneca and Moderna and they granted Medigen’s vaccine for administration on July 19.

Taiwan is the only country so far to approve the vaccine for use, according to COVID19 Vaccine Tracker run by Canada’s McGill University.

Medigen, located in the capital, said in a press release the vaccine is to be administrated to those 20 years old and above in two doses separated by 28 days.

Tsai said on Facebook after receiving the shot that it didn’t hurt and that she was in good spirits and encouraged others to get the vaccine.

“Let’s work together to improve the protection of Taiwan’s collective!” she said.

Taiwan, with a population of 23.5 million, has reported nearly 16,000 infections including 828 deaths to the pandemic, according to a live tracker of the virus by Johns Hopkins University.


Please enter your comment!
Please enter your name here